AU2002330239B2 - Method for treating retroviral infections - Google Patents

Method for treating retroviral infections Download PDF

Info

Publication number
AU2002330239B2
AU2002330239B2 AU2002330239A AU2002330239A AU2002330239B2 AU 2002330239 B2 AU2002330239 B2 AU 2002330239B2 AU 2002330239 A AU2002330239 A AU 2002330239A AU 2002330239 A AU2002330239 A AU 2002330239A AU 2002330239 B2 AU2002330239 B2 AU 2002330239B2
Authority
AU
Australia
Prior art keywords
oxide
pyridine
dimethylphenyl
sulfonyl
methylsulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU2002330239A
Other languages
English (en)
Other versions
AU2002330239A1 (en
Inventor
John A Lacadie
James Pierce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Uniroyal Chemical Co Inc
Original Assignee
Uniroyal Chemical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Chemical Co Inc filed Critical Uniroyal Chemical Co Inc
Publication of AU2002330239A1 publication Critical patent/AU2002330239A1/en
Application granted granted Critical
Publication of AU2002330239B2 publication Critical patent/AU2002330239B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
AU2002330239A 2001-10-29 2002-10-03 Method for treating retroviral infections Expired - Fee Related AU2002330239B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/021,453 US7064139B2 (en) 2001-10-29 2001-10-29 Method for treating retroviral infections
US10/021,453 2001-10-29
PCT/US2002/031836 WO2003037311A2 (en) 2001-10-29 2002-10-03 Method for treating retroviral infections

Publications (2)

Publication Number Publication Date
AU2002330239A1 AU2002330239A1 (en) 2003-07-10
AU2002330239B2 true AU2002330239B2 (en) 2008-06-26

Family

ID=21804307

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002330239A Expired - Fee Related AU2002330239B2 (en) 2001-10-29 2002-10-03 Method for treating retroviral infections

Country Status (8)

Country Link
US (3) US7064139B2 (cg-RX-API-DMAC10.html)
JP (1) JP2005515169A (cg-RX-API-DMAC10.html)
CN (1) CN1602194A (cg-RX-API-DMAC10.html)
AU (1) AU2002330239B2 (cg-RX-API-DMAC10.html)
BR (1) BR0213742A (cg-RX-API-DMAC10.html)
CA (1) CA2464303A1 (cg-RX-API-DMAC10.html)
MX (1) MXPA04004058A (cg-RX-API-DMAC10.html)
WO (1) WO2003037311A2 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1701940B1 (en) * 2003-12-23 2008-05-28 H.Lundbeck A/S 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
US7629473B2 (en) * 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
AR054393A1 (es) * 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
JP2010512333A (ja) * 2006-12-07 2010-04-22 ヘルシン ヘルスケア ソシエテ アノニム 塩酸パロノセトロンの結晶及び非晶質形
CN106674099A (zh) * 2016-12-22 2017-05-17 江苏燎原环保科技股份有限公司 一种二[2‑(n‑氧化物‑吡啶基‑2‑硫基)乙基]胺的制备方法
CN106674100A (zh) * 2016-12-22 2017-05-17 江苏燎原环保科技股份有限公司 一种三[2‑(n‑氧化物‑吡啶基‑2‑硫基)乙基]胺的制备方法
CN108956809B (zh) * 2018-06-04 2021-03-23 四川科伦药物研究院有限公司 一种检测1-(1-氯乙基)-2,3-二甲苯有关物质的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2039218A (en) * 1978-11-30 1980-08-06 Wyeth John & Brother Ltd Pharmaceutical Compositions
WO1999032450A1 (en) * 1997-12-22 1999-07-01 Pharmacia & Upjohn Company 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
JP2000302760A (ja) * 1999-02-17 2000-10-31 Hokuriku Seiyaku Co Ltd 2−メルカプトキノリン誘導体

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) * 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US3960542A (en) * 1975-03-17 1976-06-01 Uniroyal Inc. Herbicidal 2-sulfinyl and 2-sulfonyl pyridine N-oxide derivatives
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives
US4371537A (en) * 1981-08-13 1983-02-01 The Dow Chemical Company Sulfur-substituted phenoxypyridines having antiviral activity
US4616087A (en) * 1982-05-21 1986-10-07 The Dow Chemical Company 2,5-bis alkyl sulfonyl and 2,5-bis alkyl thio substituted-pyridines
US5268389A (en) * 1989-10-16 1993-12-07 Uniroyal Chemical Company, Inc. Thiocarboxylate ester compounds compositions containing the same
NZ240313A (en) * 1990-10-22 1994-04-27 Res Corp Technologies Inc Anti-retrovirus compositions containing aryl and heteroaryl derivatives
WO1995029897A1 (en) * 1994-04-29 1995-11-09 G.D. Searle & Co. METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
FR2737496B1 (fr) * 1995-07-31 1997-12-19 Centre Nat Rech Scient 4-aryl-thio-pyridin-2(1h)-ones, medicaments les contenant et leurs utilisations dans le traitement de maladies liees aux vih 1 et 2
US5770613A (en) * 1995-09-29 1998-06-23 Geron Corporation Telomerase inhibitors
US5696151A (en) * 1995-11-30 1997-12-09 Uniroyal Chemical Company, Inc. Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants
WO1998017267A1 (en) * 1996-10-23 1998-04-30 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
IL146105A (en) * 1999-04-23 2005-09-25 Tadeda Pharmaceutical Company 5-pyridyl-1, 3-azole compounds, process for producing the same and use therefor
US6316472B1 (en) * 1999-05-13 2001-11-13 Merck Frosst Canada & Co. Heterosubstituted pyridine derivatives as PDE 4 inhibitors
WO2001010842A2 (en) * 1999-08-04 2001-02-15 Millennium Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
US6498254B1 (en) * 2001-10-29 2002-12-24 Uniroyal Chemical Company, Inc. Antiretroviral compounds and compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2039218A (en) * 1978-11-30 1980-08-06 Wyeth John & Brother Ltd Pharmaceutical Compositions
WO1999032450A1 (en) * 1997-12-22 1999-07-01 Pharmacia & Upjohn Company 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
JP2000302760A (ja) * 1999-02-17 2000-10-31 Hokuriku Seiyaku Co Ltd 2−メルカプトキノリン誘導体

Also Published As

Publication number Publication date
WO2003037311A2 (en) 2003-05-08
US20040204451A1 (en) 2004-10-14
CA2464303A1 (en) 2003-05-08
CN1602194A (zh) 2005-03-30
WO2003037311A3 (en) 2003-10-16
MXPA04004058A (es) 2004-09-06
BR0213742A (pt) 2006-05-23
US20030139445A1 (en) 2003-07-24
US7064139B2 (en) 2006-06-20
US20040132778A1 (en) 2004-07-08
JP2005515169A (ja) 2005-05-26

Similar Documents

Publication Publication Date Title
US6727364B2 (en) Triazole compounds useful in treating diseases associated with unwanted cytokine activity
AU2011227398B2 (en) Modulators of Hec1 activity and methods therefor
KR20050084112A (ko) 비-뉴클레오사이드 역전사효소 억제제
CA2262252C (en) Method of treating heart failure
US20100240716A1 (en) Thiadiazoline derivative
NZ206614A (en) Dihydropyridine derivatives and pharmaceutical compositions
US7064139B2 (en) Method for treating retroviral infections
AU2002330239A1 (en) Method for treating retroviral infections
EP0554377A1 (en) Aryl and heteroaryl compounds having anti-retrovirus activity
EP2351739A1 (en) The 2-(4-substituted phenylamino) polysubstituted pyridine compounds as the inhibitors of non-nucleoside hiv reverse transcriptase, praparation methods and uses thereof
CZ20032677A3 (cs) Derivát fenylheterocyklyletheru jako inhibitor reabsorpce serotoninu, jeho použití a farmaceutický prostředek, který ho obsahuje
US6498254B1 (en) Antiretroviral compounds and compositions
EP4479399A1 (en) Adenosine ligands for the treatment of neurological disorders
JP6231195B2 (ja) スルホニルインドール誘導体およびその製造方法
AU2005219689A1 (en) Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
ATE358128T1 (de) Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation
DK171988B1 (da) Kvaternære 8-(alkyldithio)-1-(2-pyrimidyl)quinoliniumsalte
NO861756L (no) Fremgangsmaate ved fremstilling av dihydropyridinderivater.
CS244145B2 (en) Method of 4,5,6,7-tetrahydrothiazolo-(5,4-c)pyridine derivatives production
EP0330329B1 (en) Antiulcer pyrimidine derivatives
EP3319940B1 (en) New indole compounds having antiprotozoal activity and its use as well as methods for producing the same
US5182387A (en) Bis-dibenzoazepine compounds
AU2002363217A1 (en) Antiretroviral pyridine and quinoline derivatives
WO2020027905A2 (en) Analogs of 2-pralidoxime as antidotes against organophosphorus nerve agents
WO2016056606A1 (ja) ベンゾイソチアゾロピリミジン誘導体またはその塩、およびウイルス感染阻害剤ならびに医薬品

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application